Key result
Maternal anti-SSA/SSB antibodies link strongly to congenital heart block, with ~60% of mothers asymptomatic.
Why the study?
Does maternal autoantibody profile (anti-Ro/SSA and anti-La/SSB) and umbilical cord blood soluble S100A4 correlate with cardiac involvement (such as congenital heart block) in fetuses and neonates with neonatal lupus erythematosus?
Systematic Review
Does maternal autoantibody profile (anti-Ro/SSA and anti-La/SSB) and umbilical cord blood soluble S100A4 correlate with cardiac involvement (such as congenital heart block) in fetuses and neonates with neonatal lupus erythematosus?
Cardiac involvement in neonatal lupus manifests predominantly as congenital complete atrioventricular block—frequently in pregnancies of asymptomatic mothers—with umbilical cord blood soluble S100A4 emerging as a promising biomarker of clinical severity.
Answers are grounded in this paper and cite their sources.
May inform closer surveillance in autoantibody-positive pregnancies; leaves open prospective validation of S100A4 before clinical adoption.
electrocardiography (ECG).Furthermore, soluble S100A4 levels in umbilical cord blood demonstrated a reliable correlation with the clinical severity of neonatal lupus at birth. ConclusionCardiac involvement due to neonatal lupus presents high morbidity and manifests predominantly as advanced atrioventricular block, frequently occurring even in pregnancies of asymptomatic mothers.The identification of soluble S100A4 in umbilical cord blood emerges as a promising biomarker of clinical severity, reinforcing the importance of early maternal serological screening and fetal echocardiographic monitoring to optimize the management and prognosis of these neonates.
No takes yet. Share an insight, caveat, or question.
VALLE et al. (2026) conducted a systematic review in Neonatal lupus erythematosus with cardiac involvement. Maternal anti-SSA/Ro (anti-Ro60, anti-Ro52) and anti-SSB/La autoantibody exposure was evaluated on Fetal and neonatal cardiac involvement (predominantly congenital complete atrioventricular block and endocardial fibroelastosis). Maternal anti-SSA/Ro and anti-SSB/La antibodies strongly correlated with neonatal congenital heart block, with up to 60% of mothers of affected children being asymptomatic at delivery.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: